| Item Type | Name |
|
Concept
|
Age Factors
|
|
Concept
|
Immunologic Factors
|
|
Concept
|
Risk Factors
|
|
Concept
|
von Willebrand Factor
|
|
Concept
|
Time Factors
|
|
Concept
|
STAT3 Transcription Factor
|
|
Concept
|
Sex Factors
|
|
Concept
|
STAT1 Transcription Factor
|
|
Concept
|
Biological Factors
|
|
Academic Article
|
CT colonography with three-dimensional problem solving for detection of colonic polyps.
|
|
Academic Article
|
Smoking and inflammatory bowel disease.
|
|
Academic Article
|
Effects of billing and documentation requirements on the quantity and quality of teaching by attending physicians.
|
|
Academic Article
|
Comparison of routine and unprepped CT colonography augmented by low fiber diet and stool tagging: a pilot study.
|
|
Academic Article
|
Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
|
|
Academic Article
|
Surveillance for cancer and dysplasia in inflammatory bowel disease.
|
|
Academic Article
|
Agile patency system eliminates risk of capsule retention in patients with known intestinal strictures who undergo capsule endoscopy.
|
|
Academic Article
|
Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitis.
|
|
Academic Article
|
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
|
|
Academic Article
|
Colorectal cancer and dysplasia in inflammatory bowel disease.
|
|
Academic Article
|
Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data.
|
|
Academic Article
|
Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease.
|
|
Academic Article
|
Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.
|
|
Academic Article
|
Total abdominal colectomy for refractory ulcerative colitis. Surgical treatment in evolution.
|
|
Academic Article
|
Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
|
|
Academic Article
|
Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.
|
|
Academic Article
|
Do colorectal cancer patients understand that their family is at risk?
|
|
Academic Article
|
Will a 5-ASA a day keep the cancer (and dysplasia) away?
|
|
Academic Article
|
Association between colorectal cancer and urologic cancers.
|
|
Academic Article
|
Association of colorectal cancer and prostate cancer and impact of radiation therapy.
|
|
Academic Article
|
Performance of CT colonography in clinical trials.
|
|
Academic Article
|
Serum adalimumab concentration and clinical remission in patients with Crohn's disease.
|
|
Academic Article
|
Summaries for patients. Increased risk for gastrointestinal cancer in childhood cancer survivors.
|
|
Academic Article
|
Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.
|
|
Academic Article
|
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.
|
|
Academic Article
|
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.
|
|
Academic Article
|
Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.
|
|
Academic Article
|
Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease.
|
|
Academic Article
|
Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital.
|
|
Academic Article
|
Subdural hemorrhage in pediatric patients with enlargement of the subarachnoid spaces.
|
|
Academic Article
|
Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
|
|
Academic Article
|
Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases.
|
|
Academic Article
|
U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis.
|
|
Academic Article
|
Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn's Disease in the United States.
|
|
Academic Article
|
Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
|
|
Academic Article
|
Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease.
|
|
Academic Article
|
Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.
|
|
Academic Article
|
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.
|
|
Academic Article
|
Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.
|
|
Academic Article
|
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.
|
|
Academic Article
|
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
|
|
Academic Article
|
Legal Risks and Considerations Associated with Inflammatory Bowel Disease: A Primer.
|
|
Academic Article
|
Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies.
|
|
Academic Article
|
Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
|
|
Academic Article
|
A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's disease.
|
|
Academic Article
|
The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
|
|
Academic Article
|
Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies.
|
|
Academic Article
|
Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
|
|
Academic Article
|
Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors.
|
|
Academic Article
|
Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
|
|
Academic Article
|
Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease.
|
|
Academic Article
|
Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
|
|
Academic Article
|
Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2.
|
|
Academic Article
|
Real-World Experience with Tofacitinib in IBD at a Tertiary Center.
|
|
Academic Article
|
Tumor angiogenesis in primary and metastatic colorectal cancers.
|
|
Academic Article
|
Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial.
|
|
Academic Article
|
Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease.
|
|
Academic Article
|
Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study.
|
|
Academic Article
|
ACG Clinical Guideline: Ulcerative Colitis in Adults.
|
|
Academic Article
|
Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
|
|
Academic Article
|
Renin-angiotensin system promotes colonic inflammation by inducing TH17 activation via JAK2/STAT pathway.
|
|
Academic Article
|
The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know?
|
|
Academic Article
|
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
|
|
Academic Article
|
Exposure to Anti-tumor Necrosis Factor Medications Increases the Incidence of Pouchitis After Restorative Proctocolectomy in Patients With Ulcerative Colitis.
|
|
Academic Article
|
Poor Sleep Quality in Crohn's Disease Is Associated With Disease Activity and Risk for Hospitalization or Surgery.
|
|
Academic Article
|
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.
|
|
Academic Article
|
Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.
|
|
Academic Article
|
Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
|
|
Academic Article
|
Emerging treatment options for extraintestinal manifestations in IBD.
|
|
Academic Article
|
Long-term safety of vedolizumab for inflammatory bowel disease.
|
|
Academic Article
|
Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.
|
|
Academic Article
|
The Montefiore community children's project: a controlled study of cognitive and emotional problems of homeless mothers and children.
|
|
Academic Article
|
The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.
|
|
Academic Article
|
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
|
|
Academic Article
|
Vedolizumab and Anti-Tumour Necrosis Factor a Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.
|
|
Academic Article
|
Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic.
|
|
Academic Article
|
Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD.
|
|
Academic Article
|
Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn's disease.
|
|
Academic Article
|
Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
|
|
Academic Article
|
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.
|
|
Academic Article
|
Inclusion of Under-represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease.
|
|
Academic Article
|
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.
|
|
Academic Article
|
Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease.
|
|
Academic Article
|
Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis.
|
|
Academic Article
|
Identification of Risk Factors for Coexisting Sinusitis and Inflammatory Bowel Disease.
|
|
Academic Article
|
Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis.
|
|
Academic Article
|
Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic.
|
|
Academic Article
|
Low Skeletal Muscle Index Adjusted for Body Mass Index Is an Independent Risk Factor for Inflammatory Bowel Disease Surgical Complications.
|
|
Academic Article
|
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme.
|
|
Academic Article
|
Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21).
|
|
Academic Article
|
Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis.
|
|
Academic Article
|
Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis.
|
|
Academic Article
|
Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program.
|
|
Academic Article
|
Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center.
|
|
Academic Article
|
Impact of a health-system specialty pharmacy on time to upadacitinib initiation.
|